The suppression of RCC cell invasion and migration by SPAG6 overexpression, accompanied by E-cadherin upregulation and N-cadherin/vimentin downregulation, aligns with its emerging role as an EMT regulator in solid tumors. This evidence concerns the gene SPAG6 and renal cell carcinoma.